Abstracts tagged "Autoinflammatory Disease and fever"

Abstract Number: 2278 • 2018 ACR/ARHP Annual Meeting
Cryopyrinopathy across Generations: Longterm Disease Outcome
Sarka Fingerhutova¹, Jana Franova², Eva Hlavackova³, Eva Jancova⁴, Leona Prochazkova⁵, Marketa Tesarova⁶ and Pavla Dolezalová⁷, ¹Paediatric Rheumatology Unit, General University Hospital in Prague and 1st Faculty of Medicine, Charles University, General University Hospital in Prague and 1st Faculty of Medicine, Prague, Czech Republic, ²Department of Paediatric Rheumatology, University Hospital Brno, Brno, Czech Republic, Brno, Czech Republic, ³Department of Allergology and Immunology, St Ann´s Hospital Brno, University Hospital, Brno, Czech Republic, Brno, Czech Republic, ⁴Department of Nephrology, General University Hospital in Prague and 1st Faculty of Medicine, Prague, Czech Republic, ⁵Department of Rheumatology, St Ann´s Hospital Brno, University Hospital, Brno, Czech Republic, Brno, Czech Republic, ⁶Laboratory for study of Mitochondrial Disorders, Department of Paediatrics and Adolescent Medicine, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, ⁷Pediatric Rheumatology Unit, Department of Pediatrics and Adolescent Medicine, General University Hospital in Prague, Prague, Czech Republic
Background/Purpose: Cryopyrinopathies are autoinflammatory disorders (AID) caused by mutations of NLRP3 gene that lead to interleukin-1 (IL-1) overproduction with the clinical picture of periodic fever.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].